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ABSTRACT
EFFECTS OF OXIDIZED LOW DENSITY LIPOPROTEIN
ON NITRIC OXIDE PRODUCTION IN MACROPHAGES
By
Annong Huang
The effects of oxidatively modified low density lipoprotein (oxLDL) on
atherogenesis may be partly mediated by alterations in nitric oxide (NO)
production by macrophages. A major goal of this study was to identify the lipid
components in oxLDL modulating NO production. The effect of a water soluble
antioxidants (N-acetylcysteine) and lipid soluble antioxidant (alpha-tocopherol)
on NO production in macrophages was also determined. A second goal was to
determine if the effects of oxLDL occurred at the transcriptional level.
Human LDL was oxidized using an azo-initiator 2,2-azobis (2-amidinopropane)
HCI (ABAP). OxLDL markedly decreased the production of NO in LPS
stimulated RAW264.7 macrophages. This inhibition depended on the levels of
LOOH formed in oxLDL and was not due to oxLDL cytotoxicity. In contrast,
acetylated LDL (AcLDL) and native LDL showed only minor inhibition. Lipid
hydroperoxides (LOOH) and lysophosphatidylcholine (lysoPC) are the primary
products formed during LDL oxidation. 13-Hydroperoxyl octadecadienoic acid
(13-HPODE) markedly inhibited NO production, whereas lysoPC showed only
slight inhibition. Furthermore, the effects of 13-HPODE and lysoPC did not
require their uptake in an AcLDL carrier. Pre-treatment of macrophages with
alpha-tocopherol attenuated the inhibition due to oxLDL. Similarly, pre-treatment
with N-acetylcysteine attenuated the inhibition caused by oxLDL or 13-HPODE.
OxLDL was found to decrease iNOS protein and mRNA levels in RAW264.7
macrophages induced by LPS. The activation of NF-k B was slightly suppressed
after 45 minutes of treatment. 13-HPODE showed much stronger reduction of
iNOS protein levels than lysoPC. These results suggest that oxLDL may inhibit
NO production in macrophages at transcriptional level. 13-HPODE is likely to be
the most important lipid component in oxLDL for the inhibitory effect.
Antioxidants were found to preserve NO production in macrophages treated with
either oxLDL or 13-HPODE. The physiological consequences of decreased NO
production in macrophages caused by oxLDL are discussed with respect to
atherosclerosis.
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CHAPTER 1
INTRODUCTION

Oxidized LDL. Macrophages and Atherosclerosis

Oxidation of Low Density Lipoprotein
Oxidatively modified low density lipoprotein (oxLDL) is generally believed
to play an important role in the initiation of atherosclerosis (Berliner and
Heinecke 1996; Parthasarathy and others 1992; Steinbrecher and others 1990).
Immunological evidence suggests that oxidatively modified forms of low density
lipoprotein (LDL) exist in human and rabbit atherosclerotic plaques (Yla-Herttuala
and others 1989). The alterations in LDL resulting from in vitro lipid peroxidation
have been well characterized (Esterbauer and others 1992; Noguchi and others
1993; Steinberg 1997). LDL oxidation involves lipid peroxidation, epitope
alterations of apoprotein B-100 (apo B-100), hydrolysis of phospholipids and an
increase in the negative charge of LDL particles.
LDL is a spherical molecule, consisting of triglycerides and cholesteryl
esters in a hydrophobic core surrounded by a monolayer of phospholipids and
cholesterol. One large polypeptide is present termed apo B-100. LDL contains
large amounts of polyunsaturated fatty acids (PUFA) such as linoleic acid (or
octadecadienoic acid), which are very susceptible to peroxidation forming lipid
hydroperoxides (LOOH). As shown in Figure 1-1, lipid peroxidation is initiated
when a radical abstracts a hydrogen atom from a PUFA fragment (LH) present in
1
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Figure 1-1 Mechanism of Lipid Peroxidation
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LDL. The resulting carbon-center lipid radical undergoes double bond
rearrangement to form a conjugated diene. The conjugated diene reacts rapidly
with oxygen to form a lipid peroxyl radical (LOO’). In the absence of
antioxidants, the lipid peroxyl radical will abstract a hydrogen atom from an
adjacent LH to yield a LOOH and another carbon-center lipid radical that can
then continue the chain reactions.
Even though the in vivo mechanism for LDL oxidation is uncertain, LOOH
is likely to be the most abundant primary lipid oxidation product formed (Noguchi
and others 1993). In extensively oxidized LDL, nearly 50% of the phospholipids
are hydrolyzed to lysophospholipids that are the second most abundant lipid
products (Steinbrecher and others 1990) (reaction 1-1).

PLA2
phospholipid------------> lysophospholipid + free fatty acid

(1-1)

Hydrolysis of phospholipids is catalyzed by a PLA2-like activity that is intrinsic to
oxLDL but not native LDL (Parthasarathy and Barnett 1990; Reisfeld and others
1993). LDL oxidation in vitro with either Cu~ or peroxyl radicals generated from
azo-initiators yields high levels of octadecadienoic acid hydroperoxides (9HPODE and 13-HPODE) and octadecadienoic acid hydroxides (9-HODE and 13HODE) (Thomas and Jackson 1991). 13-HPODE has been found to be a
predominant form of lipid oxidation product over 13-HODE in oxLDL modified by
human monocytes (Folcik and Cathcart 1994). Increasing evidence suggests
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4
that lipoxygenase contributes to LDL oxidation during atherosclerosis (Folcik and
others 1995; Kuhn and others 1994; Scheidegger and others 1997).
Lipoxygenase catalyzes the peroxidation of octadecadienoic acid to form
predominantly the S stereoisomer over the R stereoisomer of 13-HPODE,
whereas oxidation of LDL by Cu~ forms equal amount of the S and R
stereoisomers (Folcik and others 1995). This property of lipoxygenase activity
can be distinguished from nonenzymatic lipid peroxidation. Analysis of lipid
extracts from human atherosclerotic lesions indicates that 13-HPODE is
produced from 15-lipoxygenase mediated lipid peroxidation (reaction 1-2) (Folcik
and others 1995).

15-lipoxygenase
octadecadienoic acid------------------ >13-hydroperoxyloctadecadienoic acid

02

( 1- 2)

As shown in Figure 1-1, LOOHs are unstable molecules and are rapidly
reduced to the corresponding hydroxides (LOH) by the action of cellular
peroxidases such as glutathione (GSH) peroxidases (reaction 1-3) (Thomas and
others 1990). Therefore, 9-HODE and 13-HODE found in cell-mediated (Kaduce
and others 1989) or lipoxygenase-mediated (Scheidegger and others 1997)
oxLDL as well as in aortic atherosclerotic plaques (Wang and Powell 1991)
probably originated from the corresponding less stable HPODE.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

5
GSH peroxidase
13-HPODE + 2 G S H ----------------------- > 13-HODE + GSSG

(1-3)

In the presence of metal ions, LOOHs break down to various aldehydes.
Malondialdehyde (MDA) is one of the important products that covalently binds to
positively charged lysine residues in apo B-100 and increases the negative
charge of oxLDL (Haberland and Fogelman 1985). OxLDL is no longer
recognized by the LDL receptor but is a ligand for the scavenger receptors in
macrophages and smooth muscle cells (SMC) (Haberland and others 1988;
Haberland and others 1992).

Macrophage Lipid Metabolism and Inflammatory Response
Macrophages incubated with oxLDL in vitro assume many characteristics
typical of foam cells found in early atherosclerotic lesions, whereas native LDL
incubated with macrophages does not cause foam cell formation (for reviews see
Aviram 1996; Ross 1993). The LDL receptor mediated uptake of LDL by cells is
under the regulation of intracellular cholesterol. Increased cellular free
cholesterol down-regulates the biosynthesis of the LDL receptor thereby
decreasing the further internalization of LDL. Macrophages, however, express
scavenger receptors for modified LDL such as acetylated LDL (AcLDL) and
oxLDL (Brown and Goldstein 1983). The uptake of modified LDL via scavenger
receptors is not down regulated by intracellular cholesterol thereby leading to the
accumulation of cholesteryl esters that form intracellular lipid droplets with a
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foam-like appearance. There are at least two different kinds of macrophage
scavenger receptors: class A and class B (Steinberg 1997). Class A is the
original AcLDL receptors which were described by Brown and others (Brown and
Goldstein 1983) capable of recognizing both AcLDL and oxLDL. Class A
scavenger receptors of type Al and type All have been cloned (Penman and
others 1991). A collagen domain in both type Al and All receptors binds
modified LDL. OxLDL may be the physiologically relevant form of modified LDL
since it has been found in atherosclerotic plaques (Haberland and others 1988;
Yla-Herttuala and others 1989).
Figure 1-2 shows the transformation of macrophages to foam cells and
the effects of oxLDL in the early stages of atherosclerosis. Binding of circulating
monocytes to the endothelial surface is the initial step for monocyte migration.
Endothelial adhesion molecules such as endothelial leukocyte adhesion
molecule 1 (ELAM-1), intercellular adhesion molecule 1 (ICAM-1) and vascular
cell adhesion molecule 1 (VCAM-1) are found in atherosclerotic plaques (for a
review see Holvoet and Collen 1994). OxLDL induces the expression of
endothelial adhesion molecules and facilitates the interactions between
macrophages and endothelial cells (Berliner and others 1990; Khan and others
1995; Lehr and others 1993). Furthermore, monocytes undergo proliferation and
differentiation driven by monocyte chemoattractant protein 1 (MCP-1) and growth
factors such as granulocyte-monocyte colony stimulating factor (GM-CSF) and
monocyte colony stimulating factor (M-CSF) that are secreted from endothelial
and other cells. The expression of MCP-1, GM-CSF and M-CSF are also
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LDL

monocytes
ELAM-1
ICAM-1
VCAM-1

endothelium

3
oxLDL
MCP-1
GM-CSF
M-CSF

jS

' macrophages

foam cells

Figure 1-2 A schematic outline showing foam cell formation and the effects of
oxLDL. Abbreviations: low density lipoprotein (LDL); oxidatively modified low
density lipoprotein (oxLDL); endothelial leukocyte adhesion molecule 1 (ELAM1); intercellular adhesion molecule 1 (ICAM-1); vascular cell adhesion molecule
(VCAM-1). monocyte chemoattratant protein 1 (MCP-1); granulocyte-monocyte
stimulating factor (GM-CSF); granulocyte-monocyte stimulating factor (GM-CSF)

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

8
induced by oxLDL (Cushing and Fogelman 1992; Rajavashisth and others
1990). Further study has showed that M-CSF enhances the uptake of oxLDL
and the formation of foam cells by increasing the expression of scavenger
receptors in macrophages (Ishibashi and others 1990).

Nitric Oxide and Atherosclerosis
Palmer and others. (1987) first suggested that nitric oxide (NO) accounts
for the biological activity of endothelial-derived relaxing factor (EDRF). NO is
derived from L-arginine and oxygen by a family of enzymes termed nitric oxide
synthase (NOS). NOS includes three isoforms. Macrophages and many other
cell types express inducible nitric oxide synthase (iNOS) upon stimulation by
various cytokines and bacterial derived substances such as lipopolysaccharide
(LPS). The iNOS enzyme catalyzes the production of large amounts of NO in
stimulated macrophages. Endothelial constitutive nitric oxide synthase (ecNOS)
and neural constitutive nitric oxide synthase are expressed in endothelial cells
and nervous tissues, respectively (Nathan and Xie 1994). NO plays a critical role
in maintaining vascular homeostasis. Recent evidence also shows that NO
appears to exert anti-atherogenic effects by inhibiting leukocyte adhesion,
platelet aggregation and SMC proliferation (for a review see Lloyd-Jones and
Bloch 1996). Increased systemic production of NO by supplementation with Larginine inhibits the progression of atherosclerosis (Boger and others 1996;
Wang and others 1994) and promotes the regression of preexisting lesions
(Candipan and others 1996) in hypercholesterolemic rabbits. In contrast, long
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term supplementation with the NOS inhibitor, N-nitro-L-arginine methylester,
promotes atherosclerosis in rabbits (Naruse and others 1994). NO production is
also significantly decreased during the early phases of atherosclerosis in
humans (Lloyd-Jones and Bloch 1996).
NO shows dual effects on LDL oxidation (see Figure 1-3). Most evidence
suggests that NO by itself is an antioxidant capable of inhibiting LDL oxidation in
vitro (Hogg and others 1995; Jessup and Dean 1993; Rubbo and others 1994;
Seccia and others 1996) by quenching LOO' (Hayashi and others 1995). In
contrast, NO rapidly reacts with superoxide radicals (0 '2) to produce
peroxynitrite (ONOO' ) that is a potent oxidant capable of oxidizing LDL (Hogg
and others 1993; Rubbo and others 1994). 3-Nitrotyrosine is a specific
biomarker of ONOO'-mediated protein oxidation. ONOO'-mediated LDL
oxidation may occur in vivo as indicated by the presence of 3-nitrotyrosine in
human atherosclerotic plaques (Buttery and others 1996) and in LDL isolated
from human atherosclerotic lesions (Leeuwenburgh and others 1997).
Endothelial cells and macrophages are the major cell types that produce NO in
atherosclerotic lesions as evidenced by the high levels of 3-nitrotyrosine present
in these cell types (Beckmann and others 1994). Furthermore, iNOS protein was
found in human atherosclerotic plaques and was co-localized with 3-nitrotyrosine
in macrophages (Buttery and others 1996). Inducible NO production from
macrophages may, therefore, play a key role in atherosclerosis.
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Figure 1-3 The possible roles of nitric oxide and peroxynitrite.
Abbreviations: lipid peroxyl radical (LOO*); lipid hydroperoxide (LOOH);
peroxynitrite (ONOO* ); organic peroxynitrite (LOONO); nitric oxide (NO); native
low density lipoprotein (nLDL); oxidatively modified low density lipoprotein
(oxLDL).
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Gene Regulation and Oxidative Stress

OxLDL and NO Production in Macrophages
Endothelial dysfunctions occur at the very early stages of atherosclerosis
(for a review see Lloyd-Jones and Bloch 1996). OxLDL was found to decrease
constitutive NO production in human vein endothelial cells by inhibiting the
transcription of ecNOS mRNA (Liao and others 1995). Inducible NO production
in stimulated murine macrophages was also shown to be inhibited by oxLDL
(Bolton and others 1994; Thai and others 1995; Yang and others 1994). Recent
studies further indicate that oxLDL decreases mRNA for iNOS, tumor necrosis
factor a (TNF-a), interleukin 1a (IL-1a) and interleukin ip (IL-1 p) in mouse
peritoneal macrophages (Hamilton and others 1995; Ohlsson and others 1996;
Schackelford and others 1995). However, the mechanisms whereby oxLDL
inhibits the expression of iNOS and other inflammatory related genes in
macrophages are not well understood.
Xie and others ( Xie and others 1992; Xie 1997) have provided detailed
information on the regulation of mouse iNOS gene in RAW264.7 macrophages.
Mouse iNOS gene is under quite complicated regulation. There are at least 22
transcription factor binding sites in its promotor sequence (Xie and others 1993).
The activation of NF-k B is believed to be required for the induction of iNOS by
LPS (Goldring and others 1995; Xie and others 1994). Other transcription factor
binding sites include two of each for activating protein (AP-1) and interferongamma (IFN-y). OxLDL has been found to suppress the activation of NF-k B in

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

12
LPS and /or IFN-y stimulated macrophages (Ohlsson and others 1996;
Schackelford and others 1995). Schackelford and others (1995) have suggested
that the ligation of scavenger receptors by oxLDL activates a pertussis toxin
sensitive signaling pathway in macrophages. In this model, oxLDL scavenger
receptors are coupled to a Gi protein, which initiates the hydrolysis of
phosphatidylinositol 4,5-bisphosphate (IPI2) and increases intracellular fluxes of
Ca*"". However, Schackelford and others (1995) are unable to explain why
AcLDL has no effect since AcLDL also binds to oxLDL receptors. The role of
oxidative stress on the activation of Gi proteins and the suppression of NF-k B
are also not addressed by this model.
Yang and others (1994) have found that the lipid extract but not the
aqueous extract causes the inhibitory effect of oxLDL. Lysophosphatidylcholine
(lysoPC) is considered a bioactive lipid molecule and has been suspected to
cause the inhibition. LysoPC, however, causes only slight inhibition of NO
production in murine macrophages (Yang and others 1994). The active lipid
components in oxLDL that contribute to the inhibition on NF-k B activation and
iNOS expression have not been identified.

Oxidative Stress and Gene Regulation
NF-k B and AP-1 are well recognized redox regulated transcription factors
(Flohe and others 1997; Schreck and others 1992a). NF-k B is a ubiquitous
pleiotropic transcription factor that binds to a specific DNA sequence (Flohe and
others 1997). A family of proteins that are referred to as c-Rel proteins form the
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N F- k B complex. The c-Rel proteins are classified according to their structural

homology: the first class includes p50, p52 and their precursors (i.e., p100 and
p105); the second class contains p65 (rel A), c-Rel and Rel B. N F- k B exists as
a homodimer such as p50/p50 or heterodimer such as p50/p65. The function of
NF- k B is inhibited by another family of proteins called the Ik B family. As shown

in a simplified model (see Figure 1-4), N F - k B*I k B complex is activated by the
phosphorylation and degradation of Ik B. N F- k B migrates to the nucleus, binds to
a specific D N A sequence and regulates gene expression. The p50/p65
heterodimer contributes to transactivation (Schmitz and Baeuerle 1991),
whereas the p50/p50 homodimer may bind to the same k B site thereby inhibiting
p50/p65 transactivation (Franzoso and others 1992; Plaksin and others 1993).
Furthermore, p100 and p105 proteins containing the Ik B domain also inhibit the
transactivation of N F- k B. The mechanisms whereby N F- k B regulates genes can
be quite complex.
T h e role of oxidative stress in the activation of N F- k B is controversial.

Early studies indicated that H2Oz activates NF-k B in T lymphocytes and
monocytes (Israel and others 1992; Schreck and others 1991; Suzuki and
Packer 1993). This activation was blocked by various antioxidants such as Nacetylcysteine (NAC) and pyrrolidine dithiocarbamate. Minimally oxidized LDL
(MM-LDL) has also been shown to activate NF-k B (Parhami and others 1993)
and NF-k B regulated genes such as ELAM-1, ICAM-1, VCAM-1, MCP-1, G-CSF
and M-CSF in cultured endothelial cells (Collins 1993). Recent evidence
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A simple model for the activation of NF-k B.
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indicates that the activation of NF-k B by oxidants may, however, be limited to
certain cell types (Brennan and O'Neill 1995; Hecker and others 1996).

Antioxidants and Atherosclerosis
Epidemiologic studies suggest an inverse relation between coronary
arterial disease and antioxidant intake, particularly vitamin E supplementation
(Diaz and others 1997; Steinberg 1995). Animal studies have also showed that
high dietary intake of antioxidants delays atherogenesis (Parker and others
1995; Williams and others 1992). The benefits of antioxidants in preventing
cardiovascular disease have been primarily related to protecting LDL against
oxidation (Steinberg 1995). a-Tocopherol, the major lipid soluble antioxidant in
plasma (Ingold and others 1987), effectively protects LDL lipids from
peroxidation (Steinberg 1995; Ma and others 1994). a-Tocopherol has a
chromanol ring with three methyl groups and a phytyl tail (Figure 1-5). In the
presence of reactive free radicals, a-tocopherol donates a phenolic hydrogen
atom more quickly than PUFA thereby protecting PUFA from peroxidation. In
addition, a-tocopherol has been shown to have direct effects on vascular tissues
and preserves normal vascular functions (Diaz and others 1997). Loading
endothelial cells and macrophages with a-tocopherol enhances their resistance
to oxLDL cytotoxicity (Kuzuya and others 1991). The incorporation of atocopherol into arterial cells preserves the vascular relaxation impaired by oxLDL
(Kugiyama and others 1990). a-Tocopherol inhibits SMC proliferation by
inhibiting protein kinase C (PKC) activity (Boscoboinik and others 1994).
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Furthermore, a-tocopherol inhibits monocyte adhesion to human endothelial
cells (Devaraj and others 1996). a-Tocopherol may, therefore, reduce the
clinical expression of established coronary arterial disease by reducing LDL
oxidation as well as by its direct effect on vascular tissues (Stephens and others
1996).
NAC is a non-toxic thiol-containing drug (Figure 1-5) used for the
treatment of diseases related to hypersecretion of mucus, pulmonary oxygen
toxicity, adult respiratory distress syndrome and potentially for HIV infections
(Moldeus and Cotgreave 1994). NAC functions as an antioxidant by scavenging
reactive oxygen species such as 0*2'. H20 2, HO' and hypochlorous acid. NAC is
readily deacetylated in endothelial and other cells to liberate cysteine (Moldeus
and Cotgreave 1994). NAC provides cysteine for GSH biosynthesis and is
therefore considered to be a GSH precursor. GSH is the main intracellular water
soluble antioxidant. Treatment of macrophages and endothelial cells with NAC
causes a significant increase in cellular GSH levels (Faruqi and others 1997; van
1995). Recently, NAC has been shown to effectively block the activation of NFk3

in HIV infected lymphocytes (Roederer and others 1993; van 1995) and

modulate NF-k B regulated gene expression in leukocytes (Faruqi and others
1997; Schreck and others 1992b). NAC is, therefore, considered to be an
excellent intracellular antioxidant for studying cellular redox sensitive
mechanisms.
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Specific Aims
The purpose of this research was to study the effects of oxLDL on the
regulation of murine iNOS gene expression in LPS stimulated RAW264.7
macrophages and to identify the lipid components that contribute to this
regulation. In addition, the effects of antioxidants in this model system were also
investigated. Our specific aims are:
Specific aim I

To characterize the effects of LOOH in oxLDL on inducible
NO production in stimulated RAW264.7 macrophages

Specific aim II

To compare to the effects of synthetic 13-HPODE or lysoPC
on NO production in stimulated RAW264.7 macrophages

Specific aim III

To determine whether antioxidants effect on NO production
in stimulated RAW264.7 macrophages

Specific aim IV

To study the effects of oxLDL, 13-HPODE and lysoPC on
the expression of iNOS gene in stimulated RAW264.7
macrophages.
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CHAPTER 2
MATERIALS AND METHODS

Part I — Effects of Oxidized Low Density Lipoprotein on Nitric Oxide Production in
LPS Stimulated RAW264.7 Macrophages

Overall Experimental Design
Human LDL was isolated by sequential ultracentrifugation. Aliquots of the
purified LDL were either oxidized by exposure to a water soluble azo-initiator
azobis-2-amidinopropane HCI (ABAP) or acetylated by acetic anhydride.
OxLDL, AcLDL and LDL were extensively dialyzed and the levels of a-tocopherol
as well as LOOH were determined. LDLs were diluted in RPMI-1640 medium
supplemented with 0.1% bovine serum albumin (RPMI-0.1%BSA) to give final
concentrations of 25-100 pg protein/ml before being added to macrophages. In
control experiments, an aliquot of LDL dialysate replaced oxLDL. RAW264.7
macrophage-like cells were co-incubated with LPS and various concentrations of
OxLDL, AcLDL or LDL for 24 hours in RPMI-0.1%BSA. The production of NO
was determined by measuring N 0 2' accumulation in the medium. At the end of
the experiments, cell viability and mitochondrial dehydrogenase activity were
determined.

19
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Materials
2,2’-Azobis (2-amidinopropane) HCI (ABAP) was obtained from
Polysciences, Inc. (Warrington, PA) and stored at4°C . Ethylenediaminetetraacetic acid (Na4EDTA), propyl gallate, sodium acetate, acetic anhydride,
monobasic, dibasic sodium phosphate, HCI, phosphoric acid (H3P 0 4), 3-(4,5dimethylthiazoiyl-2)-2,5-diphenyltetrazolium bromide (MTT), N-(1naphthyl)ethylenediamine dihydrochloride, sufanilamide, Escherichia coli.
lipopolysaccharide serotype 0111:B4 (LPS), and tissue culture grade bovine
serum albumin (BSA) were obtained from Sigma Chemical Co. (St. Louis, MO)
Sodium chlo

(NaCI), potassium bromide (KBr), HPLC grade methanol, and

hexane were purchased from Fisher Scientific (Fair Lawn, NJ). Absolute ethyl
alcohol was obtained from Florida Distillers Company (Lake Alfred, FL). Tocol
was a generous gift from Hoffman-La Roche Inc. (Nutley, NJ). RPMI-1640
medium without phenol red, fetal bovine serum (low endotoxin), penicillin,
streptomycin, and trypan blue were purchased from Life Technologies
(Gaithersburg, MD). Sodium dodecyl sulphate (SDS) was purchased from
Hoeffer Scientific Instruments (San Francisco, CA).

Cell Culture
RAW264.7 murine macrophage-like cell line (American Type Culture
Collection, Rockville, MD) was cultured at 37 °C in a humidified incubator (95%
air with 5% COz) in RPMI-1640 medium with 5% fetal bovine serum, 100 U/ml
penicillin, and 100 |ig/ml streptomycin. Adherent cells with 106/well or 107/dish
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were subcultured over night in 12 well falcon tissue culture plates or 60 mm petri
dishes in serum-free RPMI-0.1%BSA. The experiments were performed the next
day after the medium was replaced by fresh RPMI-0.1% BSA.

Lipoprotein Isolation
Human LDL (density 1.019-1.063 g/ml) was isolated from plasma of
healthy individuals by sequential ultracentrifugation using a Sorvall OTD-65B
ultracentrifuge (Ma and others 1994). Briefly, plasma was centrifuged at 78,303
x g (25,000 rpm) using a Type 30 Beckman rotor for no less than 18 hours at 4
°C. After a layer of chylomicron and very low density lipoprotein (VLDL) was
removed, the remaining plasma was adjusted to a density of 1.063 g/ml and
centrifuged at 267,800 x g (60,000 rpm) for 24 hours at 4 °C using a Sorvall Ti
865.1 rotor. The LDL layer was collected and dialyzed with bubbling nitrogen
gas against 3 liters of 0.15 M NaCI with 3 changes at 4 °C. LDL was filtered
(0.22 pm) and stored at 4 °C in sterile containers under N2 until used within two
weeks. This LDL preparation was further dialyzed to remove EDTA before being
added to macrophage cultures.

SDS-PAGE electrophoresis
The purity of LDL was determined by SDS-polyacrylamide gel
electrophoresis (SDS-PAGE). Electrophoresis was performed according to the
method of Laemmli (1970) using a 7.5% acrylamide gel at 20 mA in a Mighty
Small II slab gel electrophoresis unit (Hoeffer Scientific Instruments, San
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Francisco, CA). Gels were stained with Coomassie Blue R-250, and then
destained with a solution containing 10% methanol, and 7.5% acetic acid. A
single apolipoprotein polypeptide was observed that had an electrophoretic
mobility identical to that of apo B-100.

Oxidation of Low Density Lipoprotein
An aliquot of LDL (2-5 mg protein/ml) was oxidized by incubating with 15
mM ABAP in 0.15 M NaCI solution at 30 °C. LDL oxidation was stopped by
removal of ABAP by exhaustive dialysis against 3 liters of 0.15 M NaCI with 5
changes for over 24 hours at 4°C. ABAP was undetectable in the dialysate by
UV spectrometry. OxLDL was then filtered (0.22 pm) and stored as described
for LDL. LOOH and tocopherol content of oxLDL was determined (as described
below) immediately prior to macrophage experiments.
OxLDL is usually prepared by Cu** or Fe~ for long lengths of time
(Hamilton and others 1995; Schackelford and others 1995). In many cases the
transition metal ions are not removed from LDL by dialysis (Yang and others
1994). LDL also has sites that bind Cu~ very strongly and dialysis may not be
sufficient to completely remove all Cu**. Oxidized LDL with trace amount of
metal ions may influence cellular functions (Coffey and others 1995).
Furthermore, Cu~ or Fe** catalyzes the degradation of LOOH formed during LDL
oxidation (O'Brien 1969). In the present study, we oxidized LDL using ABAP
rather than transition metal ions so as to prevent nonenzymatic decomposition of
LOOH (O'Brien 1969). OxLDL prepared in this manner has been well
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characterized (Ma and others 1994) and is taken up by macrophages via
scavenger receptors that also recognizes AcLDL (Kawabe and others 1994).

Acetvlation of Low Density Lipoprotein
LDL was acetylated using acetic anhydride as described by Basu and
others (1976). Briefly, a 2.0 ml aliquot of LDL was saturated with solid sodium
acetate. An 2 pi aliquot of acetic anhydride was added to LDL several times over
a one hour period with continuous shaking, until the total amount of acetic
anhydride was 1.5 times of LDL (by weight). AcLDL was then dialyzed, filtered,
and stored as described for oxLDL.

Measurement of Lipid Hydroperoxides
LOOH levels in oxLDL were determined by a sensitive colorimetric assay
as described by Tateishi and others (1987) using a commercial kit obtained from
Kamiya Biomedical Co. (Thousand Oaks, CA). In the presence of hemoglobin,
LOOH stoichiometrically reacts with the methylene blue derivative 10-Nmethylcarbamoyl-3,7-dimethylamino-10-H-phenothiazine to generate methylene
blue of which absorbance was determined at 600 nm using a microplate reader
(Molecular Device UVmax) (Figure 2-1). Cumene hydroperoxide was used as a
standard for determining the concentrations of LOOH in oxLDL.
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Tocopherol Measurement in Lipoprotein
Tocopherols were extracted into the hexane layer after mixing a 100 ml
aliquot of LDL, AcLDL or oxLDL, an equal amount of ethanol (with tocol as
internal standard) and 200 ml hexane containing 50 mg/ml BHT. A 150 ml
aliquot of hexane was collected, dried under N2, and redissolved in 100 ml
ethanol. A 65 ml aliquot of this ethanol was injected into the HPLC system
(ISCO Inc., Lincoln, NE) equipped with a reverse phase C18 ODS (4.6 mm x 25
cm) column (ISCO Inc., Lincoln, NE). Tocopherols were eluted by methanol:H20
(99.5%:0.5%, v/v) at a flow rate of 1.5 ml/min, and its fluorescence was
monitored at an excitation wavelength of 294 nm, and an emission wavelength of
324 nm using a fluorescent detector (McPherson Model FL-750). The amounts
of tocopherols were determined using tocol as an internal standard.

Determination of Protein in Lipoprotein
The concentration of LDL protein was determined by a modified Lowry
method (Markwell and others 1978) using BSA as standard.

Tocopherol Measurement in Macrophages
Tocopherol extraction was performed using a method modified from Lang
and others (1986). After pre-treatment of macrophages with liposomes
containing a-tocopherol or control liposomes for 8 hours, cells were harvested
and washed three times with phosphate buffer saline (PBS) containing 50 pg/ml
BHT by centrifugation at 1500 rpm using ICE national centrifuge for 2 minutes.
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Cells were resuspended in PBS to give a cell density of 107 cells/ml. A 1.0 ml
aliquot of cell suspension was mixed with an equal volume of 0.16 M SDS by
vigorously vortexing. A 2.0 ml aliquot of ethanol (with tocol as internal standard)
and 2.0 ml hexane containing 50 pg/ml BHT were added to the cell lysate for
extraction. A 1.5 ml aliquot of hexane was collected after centrifugation, dried
using Virtis spinvac and redissolved in 200 jal ethanol. Cellular tocopherol
content was determined by HPLC as described above for the determination of
tocopherols in plasma.

Determination of NO Production from Macrophages
The production of NO, reflecting cellular NOS activity, was estimated from
the accumulation of nitrite (N 0 2 ), a stable breakdown product of NO, in the
medium. NOz' was measured spectrophotometrically using the Greiss reagent
as described by Green and others (1982). Briefly, Greiss reagent was freshly
prepared by mixing reagent 1 and reagent 2 prior to experiment. Reagent 1
contains 1.0% sufanilamide and 5% phosphoric acid and reagent 2 contains
0.1% naphthylenediamide hydrochloride. An aliquot of cell cultured medium was
mixed with equal volume of Greiss reagent that reacts with N 0 2‘ to form the azo
dye product immediately. The absorbance of the reaction product was recorded
at 532 nm using a microplate reader. Sodium nitrite (NaN02) dissolved in the
identical medium was used as a standard for determining the accumulation of
N 0 2' in the culture medium.
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Determination of Cell Viability bv Trypan Blue Dve Exclusion
At the end of the experiment, adherent cells were dissociated by 0.25%
trypsin and strained with 0.1% trypan blue solution. Macrophages, including live
and stained dead cells, were counted and the percent of viable cells was
determined.

MTT Assay for Determination of Cell Viability
This assay is based on the cellular reduction of 3-(4,5-dimethylthiazolyl-2)2,5-diphenyltetrazolium bromide (MTT) by mitochondrial dehydrogenase activity
in viable cells to produce a purple formazan product, which is measured
spectrophotometrically (Pirillo and others 1997). The MTT assay is widely used
to determine cytotoxicity, cell viability and cell proliferation (Clare and others
1995; Pirillo and others 1997). Briefly, at the end of each experiment, cells were
washed twice with PBS and incubated with MTT at 37 °C for 4 hours so that MTT
was converted to purple formazan crystals. Formazan product was then
solubilized by SDS in acidic solution for 16 hours at 37 °C. The mitochondrial
dehydrogenase activity was expressed as the absorbance of formazan product
at 570 nm.

Statistical Analysis
The comparison between treatments and control was performed by the
Student f-test. Means among treatments were compared by one-way ANOVA
followed by the least significant difference. A p < 0.05 was considered as
statistically significant.
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Part II — Effects of 13-HPODE and LvsoPC on Nitric Oxide Production in LPS
Stimulated RAW264.7 Macrophages

Overall Experimental Design
The effects of 13-HPODE and lysoPC on NO production in LPS
stimulated macrophages were determined. An aliquot of 13-HPODE in ethanol
was dried under nitrogen gas and redissolved in RPMI-0.1% BSA or medium
containing 50 pg/ml AcLDL carrier at 4 °C for 4-6 hours with shaking to give final
concentrations of 5-40 pM 13-HPODE. 13-HPODE were assayed as described
for LOOH in oxLDL prior to cell culture experiments. LysoPC was dissolved in
media as described for 13-HPODE to final concentrations of 50-100 pM.
RAW264.7 macrophages were co-incubated with 100 ng/ml LPS and the
indicated concentrations of 13-HPODE or lysoPC in RPMI-0.1% BSA medium
and the production of NO was determined after 24 hour stimulation. In a parallel
experiments, 13-HPODE or lysoPC in the AcLDL carrier was added to
RAW264.7 macrophages alone with LPS and NO production was determined
after 24 hours. At the end of the experiments, cell viability, mitochondrial
dehydrogenase activity and DNA content of the cells were determined.

Materials
Soybean lipoxygenase, octadecadienoic acid, boric acid, copper sulphate
(C uS 04), acetaldehyde, and chloroform were obtained from Sigma Chemical
Company (St. Louis, MO). Ethyl ether was obtained from Aldrich Chemical
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Company, Inc. (Milwaukee, WI). Egg lysolecithin (lysophosphatidylcholine) was
obtained from Matreya Inc. (Pleasant Gap, PA). Diphenylamine was from J.T.
Baker Chemical Co. (Phillipsberg, NJ). Perchloric acid and glacial acetic acid
were purchased from Fisher Scientific (Fair Lawn, NJ).

Synthesis and Purification of 13-HPODE
13-HPODE was prepared by a method modified from Egmond and others
(1976). Briefly, a 100 ml aliquot of 1 mM octadecadienoic acid in 0.1 M sodium
borate buffer (pH 9.0) was incubated with 3.7 x 104 U of soybean lipoxygenase
on ice with gentle air bubbling for over 12 hours.
The conversion of octadecadienoic acid to 13-HPODE (see reaction 1-2)
was monitored by thin layer chromatography (TLC). A 2.0 ml aliquot of borate
buffer reaction mixture was acidified to pH 3.0 and 13-HPODE was extracted into
ethyl ether which was then evaporated. 13-HPODE was redissolved in 2.0 ml
ethanol and a 100 (il aliquot was applied to a Silica G TLC plate,
octadecadienoic acid in ethanol was used as a standard. Octadecadienoic acid
and 13-HPODE were then resolved using a solvent system containing ethyl ether
: chloroform : acetic acid (100 : 100 : 1 0) (v/v/v) in 1.5 hours. Spots for
octadecadienoic acid and 13-HPODE were visualized by charring with
10%CuSO4 and 8% H3P 0 4 at 170-180 °C for 20 minutes. The conversion was
determined by comparing the density of spot for 13-HPODE with the total density
of spots for both octadecadienoic acid and 13-HPODE.
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The reaction was stopped by lowering the pH to 3.0 when the conversion
was completed. 13-HPODE was extracted in ethyl ether which was completely
evaporated. The resulting 13-HPODE was redissolved in 15 ml absolute
ethanol, filtered using an Acrodisc CR PTFE 0.2 pin filter (GelmanSciences, Ann
Arbor, Ml) and stored at -20 °C. The final concentration reached 7.5 mM as
determined from the absorbance at 234 nm using a molar absorptivity of 25,000
M‘1cm'1. The LOOH value determined by this method was in agreement with the
value obtained from the colorimetric assay described in Part I.

Measurement of Cellular DNA Content bv the DPA Assay
Cellular DNA content was quantified using diphenylamine (DPA)
according to the method described by Natarajan and others (1994). Briefly, at
the end of each experiment, cells were washed with PBS and incubated with
DPA in glacial acetic acid at 37 °C for 24 hours in the presence of acetaldehyde
and perchloric acid. The blue reaction product of DPA was quantified by
measuring OD at 650 nm. A standard curve was generated by incubating
varying numbers of cells with DPA and the ODs generated correlated fairly well
with cell numbers.

Part III — Effects of a-Tocopherol and N-Acetvlcvsteine on the Decreased Nitric
Oxide Production Caused bv OxLDL and 13-HPODE

Overall Experimental Design
The effects of antioxidants such as a-tocopherol and NAC on the
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inhibition of NO production caused by oxLDL or 13-HPODE were determined.
RAW264.7 macrophages were pre-incubated with either liposomes containing atocopherol, control liposomes or NAC for 8 hours before treatment with LPS and
oxLDL or 13-HPODE. The pre-incubation time for NAC was within the range
used by Irani and others (1997). At the end of the experiments, cell viability and
DNA content of the cells were determined.

Materials
N-acetyl-L-cysteine was obtained from Sigma Chemical Company (St.
Louis, MO). a-Tocopherol liposomes and control liposomes were generous gifts
from SEQUUS™ Pharmaceuticals Inc. (Menlo Park, CA).

Part IV - Regulation of iNOS Gene Expression bv Oxidized Low Density
Lipoprotein in LPS Stimulated RAW264.7 Macrophages

Overall Experimental Design
RAW264.7 macrophages were co-incubated with LPS and the indicated
concentrations of oxLDL, AcLDL or LDL for 24 hours as described in part I. The
accumulation of N 0 2' in the medium was measured and the adherent cells were
washed with PBS followed by the extraction of cellular proteins. The iNOS
protein was analyzed by the Western blotting technique. Similarly, the effects of
13-HPODE and lysoPC on iNOS protein levels were also determined. The iNOS
mRNA levels were analyzed by Northern blotting after macrophages were
stimulated with LPS for 6 hours in the presence or absence of oxLDL. For the
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detection of NF-k B activation, RAW264.7 macrophages were stimulated for the
lengths of time varying from 0 to 120 minutes. Nuclear proteins were extracted
and the activation of NF-k B was detected by the electrophoretic mobility shift
assay (EMSA). The effects of oxLDL on NF-k B activation was determined by
EMSA after 45 minute incubation with LPS in the absence or presence of oxLDL.
In control experiments, an aliquot of oxLDL dialysate was used to replace oxLDL.

Materials
NF-k B oligonucleotide, human recombinant NF-k B p50, mouse iNOS
cDNA, mouse GADPH cDNA, 32P-dCTP, herring sperm DNA, and random primer
labeling system were obtained from Promega (Madison, Wl). An electrophoretic
gel shift assay (EMSA) kit, and positively charge nylon membrane were
purchased from Boehringer Mannheim Corporation (Indianapolis, IN). Anti-p50
and anti-p65 antibodies were obtained from Biotechnology, Inc. (Santa Cruz,
CA). Rabbit anti-mouse iNOS antibody was from Transduction Laboratory
(Lexington, KY). An enhanced chemiluminescent detection kit, the Western
nitrocellulose membrane, and nylon membrane for Northern blot were purchased
from Amersham Life Science (Arlington Heights, IL). Horseradish peroxidase
conjugated anti-rabbit polyclonal antibody, leupeptin, antipain,
phenylmethylsulfonyl fluoride (PMSF), dithiothreitol (DTT), agarose, formamide,
formaldehyde, poly dl-dC, isopropanol, MOPS buffer, Tween-20, HEPES, TrisGlycine SDS buffer, magnesium chloride, TEMED, glycerol, nonidet-P40, and
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Kodak X-OMAT AR film were obtained from Sigma Chemical Company (St.
Louis, MO). Acrylamide, and bis-acrylamide were purchased from Hoeffer
Scientific Instruments (San Francisco, CA).

Cellular Protein Extraction
Cellular proteins were extracted following the instructions provided by
Transduction Laboratory (Lexington, KY). Briefly, after stimulation for 24 hours,
1 x 106 adherent macrophages were rinsed once with cold PBS, and lysed by 0.1
ml of boiling electrophoresis sample buffer containing 125 mM Tris-HCI, pH 6.8,
2% SDS, 5% glycerol, 1% mercaptoethanol, and 0.003% bromophenol blue.
The cell lysate was collected into the Eppendorf centrifuge tubes, and boiled for
an additional 5 minutes.

Western Blot Analysis
Gel electrophoresis of cellular proteins was performed according to the
method of Laemmli (1970). Twenty pg of proteins was separated on a 8% SDSPAGE with Tris-Glycine SDS running buffer (pH 8.3) at 25 V in a Mighty Small II
slab gel electrophoresis unit (Hoeffer Scientific Instruments, San Francisco, CA)
for 1.5 hours. Proteins were electrically transferred from the gel to a
nitrocellulose membrane with Tris-Glycine transferring buffer (pH 8.3) with 20%
methanol for 1.0 hour. The iNOS protein was detected using the enhanced
chemiluminescence kit from Amersham Life Science (Arlington Heights, IL).
Briefly, the blots were incubated with blocking buffer (PBS pH 7.0, 2% non-fat
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milk, 0.1% Tween-20) for 1.0 hour before incubation with the rabbit polyclonal
antiserum against the C terminal (961 to 1144 amino acids) of mouse iNOS
(Transduction Lab, Lexington, KY) at 1:20,000 dilution. After 60 minute
incubation at room temperature, the blots were washed three times with PBS
(0.1% Tween-20). Anti-rabbit horseradish peroxidase-conjugated antibody at
60:000 dilution as a secondary antibody was incubated with the blots for 1.0
hour. The blots were then washed twice with assay buffer, and a 2.0 ml aliquot
of substrate plus enhancer mixture was evenly added onto the blots. The
photograph of iNOS protein was obtained by exposure to Kodak film for 10-25
minutes.

RNA Extraction
Total cellular RNA was isolated from RAW264.7 macrophages by acidguanidinium phenol-chloroform method using RNAzol™ B RNA isolation kits
(TEL-TEST, Inc., Friendswood, TX). Briefly, after removing the medium, 8 x 10s
adherent cells were lysed in 1.0 ml RNAzol™ B solution by pipetting up and
down several times. The lysate was collected and mixed with 100 pi of
chloroform by inversion. The aqueous fraction of the mixture was collected after
centrifugation at 12,000 g for 15 minutes at 4 °C, and mixed with another 100 pi
aliquot of chloroform followed by vigorously vortexing. After three extractions,
the aqueous fraction was collected to a fresh tube followed by an additional wash
with 500 pi ethanol. RNA was then precipitated with 500 pi isopropanol at -20 °C
for at least 30 minutes followed by centrifugation at 7500 g for 8 minutes. After
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the supernatant was discarded, RNA pellet was dried, redissolved in 50 pi of
DEPC-treated distilled H20 and stored at -70 °C. The concentration of RNA was
quantified by measuring the absorbance at 260 nm (1 OD= 40 pg/ml), and the
purity of RNA was determined by the OD ratio at 260 nm/280 nm that was at
least I.6 in all samples.

Radio Labeling of DNA Probes
Mouse iNOS and glyceraldehyde-3-phosphodehydrogenase (GAPDH)
cDNA probes were radiolabeled with a 32P-dCTP using random primer labeling
system following the manufactural’s instructions (Promega, Madison, Wl).
Briefly, 30 pg of DNA for iNOS or GAPDH was denatured by incubation at 100 °C
for 5 minutes and chilled on ice. Thirty pg of cDNA was mixed with 10 pi of 5 x
labeling buffer, 2 pi of a mixture for dATP, dTTP and dGTP, 2.0 pi of nuclear-free
BSA, 5 pi of a 32P-dCTP (50 p Ci, 3000 Ci/mmole) and 5 units of DNA
polymerase I. The mixture with a total volume of 50 pi was incubated at 37 °C
for 1.0 hour until the polymerase reaction was close to complete. The labeled
DNA was then denatured by heating to 100 °C for 5 minutes, and chilled on ice
before hybridization.

Northern Blot Analysis
Northern blotting was performed as described by Gong and others (1994).
Briefly, an aliquot of suspension containing 20 pg of RNA was dried by vacuum
centrifugation and lyophilized into a 20 pi aliquot of denaturing and loading buffer
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(45% formamide, 6% formaldehyde, 5% glycerol, bromophenol blue in 20 mM
MOPS buffer). RNA samples were denatured by incubation at 100 °C for 2
minutes before loading into the gel. RNA was fractionated by electrophoresis on
a 1% agarose gel containing 2% formaldehyde using 1 x MOPS running buffer at
100 V for approximately 2 hours until bromophenol blue dye migrated 3/4 of the
gel. RNA on the gel was examined, and photographed on UV transilluminator.
The eukaryotic RNA of two abundant species 28S rRNA (approximately 5 Kb),
and 18S rRNA (approximately 2 Kb) was visualized. After formaldehyde was
completely removed from the gel by three washes using 10 x SSC buffer (1.5 M
NaCI, 0.15 mM sodium citrate, pH 7.0), RNA was then transferred over night
from the gel to a nylon membrane using 10 x SSC buffer.
The blots were pre-hybridized in 0.5 M phosphate buffer (pH 7.2, 7%
SDS, 100 pg/ml herring sperm DNA) at 65 °C for 2-4 hours, and hybridized with
a 32P-dCTP labeled iNOS cDNA at 65 °C for 15 hours. Non-hybridized probes
were removed by three washes with 0.1 M phosphate buffer at room temperature
(10 minutes for each wash) followed by other three washes with 0.05 M
phosphate buffer at 65 °C (15 minutes for each wash). The autoradiography of
iNOS mRNA was obtained by exposure to Kodak X-OMAT AR film for 24-48
hours at -70 °C. The a32P-dCTP labeled GAPDH cDNA was used in the second
hybridization as an internal standard for normalizing the variation between
samples.
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Nuclear Protein Extraction
Nuclear extracts were obtained essentially as described by Staal and
others (1990). After stimulation, adherent cells (1 x 107) were harvested and
washed twice in ice-cold PBS by centrifugation for 30 sec at 15,600 x g. The
pelleted cells were then washed once in 0.4 ml of low salt buffer [10 mM HEPES,
pH 7.8/ 10 mM KCI/2 mM M gC lj/1 mM (DTT)/ 0.1 mM EDTA] containing
protease inhibitors [0.5 mM of phenylmethylsulfonyl fluoride (PMSF), 5 pg/ml of
antipain and 5 pg/ml of leupeptin]. After incubation of cells on ice for 15 min, a
25 pi aliquot of 10% nonidet P-40 solution was added to lysis the cells. Nuclei
were pelleted at 15,600 x g for 30 seconds, and resuspended in 50 pi of high salt
buffer [50 mM HEPES, pH 7.8/ 50 mM KCI/ 300 mM NaCI/ 0.1 mM EDTA/ 1 mM
DTT/ 0.1 mM PMSF/10% glycerol (v/v)]. The mixture was stand on ice for 20
minutes followed by centrifugation at 15,600 x g for 5 minutes. The clear
supernatant containing nuclear proteins was collected, and stored at -80 °C.

Protein Determination
Protein concentrations of cell extract (for Western blotting), and nuclear
extract (for EMSA) were determined by the BCA protein assay using a
commercial kit from Pierce Chemical Co. (Rockford, IL). Protein samples were
diluted with PBS before protein determination in order to minimize the
interference from the ingredients in lysate buffer (for Western blotting), and high
salt buffer (for EMSA). BSA dissolved in the diluted sample buffer or the diluted
high salt buffer was used as a protein standard.
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Electrophoretic Mobility Shift Assay (EMSA) for NF-k B Activity
The activation of NF-k B was detected by chemiluminescent EMSA using a
commercial kit obtained from Boehringer Mannheim Co. (Indianapolis, IN). The
steroid hapten digoxigenin (DIG) was bound to a 126 bp NF- k B oligonucleotide
(oligo), and recognized by anti-DIG antibodies (anti-DIG) linked to alkaline
phosphatase (AP). Labeled NF-k B oligo was visualized with AP-conjugated antiDIG, and lumigen PPD chemiluminescent substrate according to the procedure
detailed in the Genius System User's Protocol.
The double stranded oligo for NF-k B was labeled at the 3’ end by adding
the following reagents (on ice): 4 pi of 5 x labeling buffer, 4 pi of CoCI2, (final
concentration of 5 pM), NF-k B oligo (final concentration of 0.2 pmol/pl), 1 pi of
DIG-11-ddUTP (final concentration of 0.2 pM), 1 pi of terminal transferase (final
concentration of 2.5 units/pl) and H20 to a final volume of 20 pi. After incubation
at 37 °C for 15 minutes, DIG labeled oligo was precipitated with 100% chilled
ethanol followed by three washes in 70% chilled ethanol by centrifugation at
15.600 x g for 5 minutes. The pelleted oligo was then vacuum dried and
redissolved in 25 pi TEN buffer [10 mM Tris-HCI, pH 8.0/1 mM EDTA/0.1 M
NaCI],
The reaction of DIG-labeled NF-k B oligo, and NF-k B protein was
performed by adding the following reagents (on ice): 3 pi of 5 x binding buffer (20
mM HEPES, pH 7.6, 20 mM NaCI, 30 mM NaCI, 1 mM EDTA, 1 mM
dithiothreitol, 10 mM (NH4)2S 0 4, 50 ng/pl poly d(l-C), 0.05% Tween 20), 1 pg of
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salmon sperm DNA, 1 pg of BSA, 2 pi of DIG-labeled NF-k B oligo (140 fmol/pl),
15 pg protein of nuclear extract, and H20 to a final volume of 15 pi. The reaction
was performed at room temperature for 15 minutes, and stopped by adding 4 pi
of loading buffer.
The oligo-protein complex and free oligo were separated on a 5% non
denatured polyacrylamide gel (20:1 acrylamide: bisacrylamide) electrophoresis in
22.5 mM Tris-borate (pH 8.3, 5 mM EDTA) running buffer at 90 V for 1.5 hours
using an electrophoresis unit SE200 (Hoeffer Scientific Instruments, San
Francisco, CA). The oligo-protein complex and free oligo were transferred to a
positively charged nylon membrane using the PolyBlot transfer system Model
SBD-100 (American Bionetics, Hayward, CA), and cross linked to membrane by
exposure to UV light. Labeled oligo-protein complex, and oligo were recognized
by AP-conjugated anti-DIG. AP catalyzed the conversion of lumigen PPD
substrate into a chemiluminescent molecule that was visualized by exposure to
Kodak Xomat AR film for 1-2 hours.

EMSA Supershift Assay
This assay detects the specific antibody bound complex by following the
procedure for EMSA. Antibodies against NF-k B p50 and p65 subunits bind to
the NF-k B dimers resulting in a slower mobility during electrophoresis. Briefly,
the experimental procedures were identical to that of EMSA except that 1 pi of
antibodies were added to the binding reaction mixture as described above before
incubation for 30 minutes instead of 15 minutes.
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Densitometry Analysis
The lumigrams of iNOS protein, iNOS mRNA and NF- k B bands from
electrophoresis were analyzed using a Scan Maker II flat bed scanner connected
to a computer. The TIFF images were quantified using the Sigma gel
densitometry software (Jandel Scientific Co., San Rafael, CA)
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CHAPTER 3
RESULTS

Part I - Effects of Oxidized Low Density Lipoprotein on Nitric Oxide Production
in LPS Stimulated RAW264.7 Macrophages

The Production of Nitric Oxide in LPS Stimulated RAW264.7 Macrophages
The production of NO by RAW264.7 macrophages, as estimated by the
accumulation of N 0 2' in the medium, was dependent on the concentrations of
LPS (Figure 3-1). A nearly linear accumulation of NO was observed at
concentrations of LPS between 0 and 100 ng/ml. Furthermore, a 5-6 hour lag
time was observed before significant amount of N 0 2' was produced, and the
subsequent accumulation of NOz' continued for over 24 hours. No detectable
amount of NO was produced in RAW264.7 macrophages without stimulation.

Oxidative Characteristics of OxLDL and the Inhibition Potential on NO Production
in LPS Stimulated RAW264.7 Macrophages
OxLDL was prepared by oxidizing LDL using ABAP that can be removed
from LDL preparations by extensive dialysis. Figure 3-2 shows that oxidation of
LDL led to the consumption of a-tocopherol, and the formation of LOOH in
oxLDL. a-Tocopherol at an initial level of 21.4 nmol/mg LDL protein completely
disappeared within 2 hours of oxidation whereas LOOH gradually accumulated
as a function of time. OxLDL was extensively dialyzed to completely remove
41
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Figure 3-1. Time course of NO production induced by varying concentrations of
LPS in RAW264.7 macrophages. Data points represent means + S.D. of
triplicate samples for a single experiment. These results are representative of
three separate experiments.
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Figure 3-2. Oxidative characteristics of oxLDL. Human LDL was oxidized for
2.5, 5 and 8 hours and the LOOH content was measured by a colorimetric assay
and a-tocopherol content was determined by HPLC.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

44
ABAP before being used in the cell culture experiments. The oxLDL dialysate
contained no measurable levels of LOOH. Our first series of experiments was
designed to examine the extent of LDL oxidation on NO production in LPS
stimulated macrophages. Figure 3-3 shows that oxLDL containing higher levels
of LOOH exerted stronger inhibition on NO production. The oxLDL dialysate,
however, had no effect on NO production in LPS stimulated macrophages (data
not shown). Furthermore, oxLDL alone did not induce NO production in
unstimulated macrophages (data not shown). These results suggest that LOOH
levels determine the inhibition potential of oxLDL on NO production in RAW264.7
macrophages. The concentration dependent experiments, as shown in Figure 34, indicate that NO production in LPS stimulated macrophages was markedly
inhibited by increasing concentrations of oxLDL in a nonlinear fashion. The rate
of inhibition was greater at low concentrations than at high concentrations.

OxLDL on Cell Viability and Cellular Dehydrogenase Activity
To determine whether the inhibition is due to oxLDL cytotoxicity, cell
viability was measured. At the end of experiments shown in Figure 3-3, 4, and 5,
cell viability was maintained above 95% as accessed by trypan blue dye
exclusion method (data not shown). Moreover, oxLDL did not show any
cytotoxicity as determined by mitochondrial dehydrogenase activity using the
MTT assay (see Table 3-1). Mitochondrial dehydrogenase activity, in fact, was
slightly increased by the treatment of high levels of oxLDL, which may indicate a
slight mitogenic effect of oxLDL.
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Figure 3-3. Influence of LDL oxidized to varying extent on NO production in LPS
stimulated RAW264.7 macrophages. OxLDL preparations (100 pg protein/ml)
containing 25, 120 and 230 pM LOOH were added to LPS stimulated RAW264.7
macrophages. Nonoxidized LDL plus LPS was used as a control (no LOOH).
Data points represent means + S.D. of triplicate samples for a single experiment.
The means with * are significantly different from treatment with LPS plus
nonoxidized LDL (Student’s t test). These results are representative of three
separate experiments.
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Figure 3-4. Concentration effect of oxLDL on NO production in LPS stimulated
RAW264.7 macrophages. OxLDL containing 2.29 pmol LOOH /mg protein was
diluted in the medium to give final concentrations of 0, 25, 50, 75 or 100 pg
protein/ml before being added to LPS stimulated RAW264.7 macrophages.
Data points represent means + S.D. of triplicate samples for a single experiment
The means with * are significantly different from treatment with LPS (Student’s t
test). These results are representative of three separate experiments.
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TABLE 3-1

EFFECT OF OXLDL ON DEHYDROGENASE ACTIVITY
Treatment

Dehydrogenase Activity
(OD at 532nm)

Dialysate + LPS

0.41 +0.01

OxLDL (50 jag/ml) + LPS

0.41 ± 0 .1 0

OxLDL (75 ng/ml) + LPS

0.42 ± 0.00

OxLDL (100 ng/ml) + LPS

0.43 ± 0 .0 1 *

At the end of the experiments shown in Figure 3-4, macrophages were washed
with PBS and mitochondrial dehydrogenase activity was measured as 532 nm
absorbance with the MTT assay as described in Materials and Methods. Values
are means ± S.D. for triplicate samples. The mean with * is significantly different
from treatment with LPS plus dialysate (p<0.05, Student’s t test). The data are
representative of three separate experiments.
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Comparison of OxLDL. AcLDL and LDL on NO Production in LPS Stimulated
RAW264-7 Macrophages
OxLDL and AcLDL, but not native LDL, were taken up by scavenger
receptors with the accumulation of cholesteryl esters in RAW264.7 macrophages
(data not shown). To determine whether AcLDL mediated uptake of modified
LDL is required for the inhibition of NO production, we compared the effects of
oxLDL, AcLDL, and LDL on NO production in stimulated macrophages. As
shown in Figure 3-5, oxLDL (with 750 nmol LOOH/mg protein) inhibited NO
production by 61%, whereas AcLDL and LDL with the same protein
concentrations showed inhibition of 12% and 18%, respectively. The slight
inhibition observed for AcLDL, and LDL may be due to the mild oxidation
occurring during the extensive dialysis procedures. In fact, AcLDL and LDL
contained LOOH levels of 36 and 42 nmol/mg protein, respectively. These
results suggest that oxidative modification of LDL is a key factor causing
inhibition on NO production in RAW264.7 macrophages. Furthermore, AcLDL
mediated uptake is not sufficient to cause strong inhibition.

Part II - Effects of 13-HPODE and LvsoPC on Nitric Oxide Production in LPS
Stimulated RAW264.7 Macrophages

Comparison of 13-HPODE and LvsoPC on Inhibiting NO Production in LPS
Stimulated RAW264.7 Macrophages
In order to identify the active lipid components of oxLDL that contribute to
the inhibition on NO production, the effects of 13-HPODE and lysoPC were

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

49

50
_to

ai
o
CO
o

40 -

o

E
c

CM

30

o
z

o

20

CO
Z3

E
§

<

10

Control

LPS

OxLDL AcLDL
+LPS
+LPS

LDL
+LPS

Figure 3-5. Comparison of oxLDL, AcLDL and LDL on NO production in LPS
stimulated RAW264.7 macrophages. Data points are means + S.D. for triplicate
samples. The means with different letter superscripts are significantly different
(p<0.05, one way ANOVA).
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studied in LPS stimulated macrophages. 13-HPODE or lysoPC was
incorporated into AcLDL carrier before being added to macrophages. Figure 3-6
shows that, in the presence of AcLDL carrier, 35 pM of 13-HPODE markedly
inhibited NO production whereas 50 pM of lysoPC was not effective.
Surprisingly, a similar inhibition of 13-HPODE was also observed in the absence
of AcLDL carrier. LysoPC, at the concentration of 50 pM, was also not effective
in the absence of AcLDL. Furthermore, neither 13-HPODE nor lysoPC induced
NO production in unstimulated macrophages (data not shown). These results
suggest that 13-HPODE is much more potent than lysoPC for inhibiting NO
production in LPS stimulated macrophages. In addition, AcLDL carrier mediated
uptake may not be required for 13-HPODE, and lysoPC to inhibit NO production
in stimulated macrophages.

Concentration Dependence of 13-HPODE and LvsoPC on NO Production in LPS
Stimulated RAW264.7 Macrophages
Figure 3-7 shows that increasing concentrations of 13-HPODE resulted in
a progressive inhibition of NO production in LPS stimulated macrophages. As
observed in oxLDL, 13-HPODE showed a nonlinear inhibition of NO production
with the rate of inhibition being greater at low concentrations than at high
concentrations. 13-HPODE did not induced the production of NO in
unstimulated macrophages (data not shown). Compared to 13-HPODE, lysoPC
moderately inhibited NO production induced by LPS, and significant inhibition
was observed only above 80 pM lysoPC (Figure 3-8). Cell viability as
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Figure 3-6. Comparison of 13-HPODE and lysoPC on NO production in LPS
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triplicate samples for a single experiment. Treatments with 13-HPODE plus LPS
are significantly different from treatments with LPS alone in the absence (*) or
presence (#) of AcLDL (Student’s t test). These results are representative of
three separate experiments.
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experiments.
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determined by the MTT assay, and cell number as measured by the DPA assay,
however, were not significantly decreased by 13-HPODE or lysoPC in the
concentrations used in these experiments (see Table 3-2). These data suggest
that the marked inhibition of NO production observed for 13-HPODE is not a
general property of detergent like lipids.

Part III — Effects of Antioxidants on the Decreased Nitric Oxide Production
Caused bv OxLDL and 13-HPODE in RAW264.7 Macrophages

Pre-treatment of RAW264.7 Macrophages with g-Tocopherol Attenuates the
Inhibition of NO Production Caused bv OxLDL
To determine whether an increased cellular content of a-tocopherol
influences NO production, RAW264.7 macrophages were enriched with atocopherol by pre-incubation with a-tocopherol containing liposomes before
treatment. After 8 hours of pre-incubation, cellular levels of a-tocopherol
increased to 16.56 + 2.1 nmol/107cells with treatment of a-tocopherol liposomes.
a-Tocopherol was undetectable in cells treated with control liposomes. As
shown in Figure 3-9, the increased cellular a-tocopherol attenuated the inhibition
caused by oxLDL by about 30%. a-Tocopherol, however, neither induced NO
production in unstimulated macrophages nor altered NO production in stimulated
macrophages (data not shown). These data suggest that the inhibition caused
by oxLDL can be partially reversed by increasing cellular levels of a-tocopherol.
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TABLE 3-2 EFFECTS OF 13-HPODE AND LYSOPC ON
DEHYDROGENASE ACTIVITY AND CELL DENSITY
Treatment

106celIs/well
(DPA DNA Assay)1

Dehydrogenase Activity
(MTT assay OD at
532nm)2

Control

1.49 ± 0 .0 7

0.42 ± 0.01

LPS

1.33 + 0.03*

0.43 ±0.01

50 pM LysoPC + LPS

1.21 ± 0 .0 7 *

0.43 ±0.01

100 pM LysoPC + LPS

1.30 ± 0 .0 2 *

0.43 ±0.01

5 pM HPODE + LPS

ND

0.42 ± 0.02

10 pM HPODE + LPS

ND

0.42 ± 0.02

15 pM HPODE + LPS

1.34 ± 0 .0 3 *

ND

20 pM HPODE + LPS

ND

0.42 ±0.01

30 pM HPODE + LPS

1.22 ± 0 .0 5 *

0.43 ±0.01

45 pM HPODE + LPS

1.29 ± 0 .0 3 *

ND

The DPA and MTT assay were performed at the end of the experiments shown
in Figure 3-6, 3-7, 3-8. 1Macrophage DNA contents were determined by the
DPA assay. Cell numbers were calculated from 532 nm absorbance using a
standard curve generated from varying numbers of cells. 2Macrophages
mitochondrial dehydrogenase activity was measured as 532 nm absorbance with
the MTT assay. Values are means ± S.D. for triplicate samples. The means
with * are significantly different from control (p<0.05, Student’s t test). ND, not
determined. The data are representative of three separate experiments.
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Figure 3-9. Effect of a-tocopherol pre-treatment on the inhibition caused by
oxLDL in LPS stimulated RAW264.7 macrophages. Liposomes containing atocopherol or control liposomes were pre-incubated with RAW264.7
macrophages for 8 hours before treatment with 100 |ag/ml oxLDL and 100 ng/ml
LPS. Data points represent means + S.D. of triplicate samples for a single
experiment. *The mean of pre-treatment with a-tocopherol containing liposomes
is significantly different from pre-treatment with blank liposomes (Student’s t
test). These results are representative of three separate experiments.
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Pre-treatment of RAW264.7 Macrophages with NAC Attenuates the Inhibition of
NO Production Caused bv OxLDL
To determine whether an increased intracellular water soluble antioxidant
NAC influences NO production, RAW264.7 macrophages were pre-incubated
with NAC for 8 hours before treatment. Figure 3-10 shows that pre-incubation of
macrophages with NAC significantly attenuated the inhibition of NO production
caused by oxLDL. The effects of NAC were dose dependent. NAC became
effective at 5.0 mM and completely reversed the inhibition at a concentration of
10.0 mM. Cell viability was maintained above 95%. Cell number was not
increased by NAC treatment as assessed by the DPA assay (Table 3-3). NAC,
however, showed cytotoxicity when the concentration reached 20.0 mM.
Furthermore, NAC at a concentration of 10.0 mM potentiated NO production in
LPS stimulated macrophages by about 25%. NAC alone, however, did not
induce NO production in RAW264.7 macrophages. These data suggest that the
inhibition caused by oxLDL was completely reversed by pre-treatment with 10.0
mM NAC.

Pre-treatment of RAW264.7 Macrophages with NAC Attenuates the Inhibition
Caused bv 13-HPODE
To determine whether an increased intracellular water soluble antioxidant
NAC influences NO production, RAW264.7 macrophages were pre-incubated
with NAC for 8 hours before treatment. Figure 3-11 shows that pre-treatment of
macrophages with NAC significantly attenuated the inhibition of NO production

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

100
J/>

H)
o
co
o
o
E
c,
'

f

80 -

60 -

CM

O

z

c
o
JO
3
E
3

40 -

20

-

8

<

0
NAC (mM)

0.0

10.0

10.0
LPS

0.0
LPS

0.0
LPS
OxLDL

OxLDL OxLDL

10.0
LPS
OxLDL

Figure 3-10. Effect of NAC pre-treatment on the inhibition caused by oxLDL in LPS stimulated RAW264.7 macrophages.
RAW264.7 macrophages were pre-incubated with indicated concentration of NAC for 8 hours before treatment with 100
pg/ml oxLDL and 100 ng/ml LPS. Data points represent means + S.D. of triplicate samples for a single experiment.
Treatment with LPS (##) is significantly different from that pre-treated with NAC (#). Treatments with LPS and oxLDL (**)
are significantly different from that pre-treated with NAC (*) (Student’s t test). These results are representative of three
separate experiments.
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TABLE 3-3 CELL DENSITY AFTER TREATMENT WITH NAC AND OXLDL
Treatment

106cells/well
(DPA DNA Assay)

Control

1.48 + 0.09a

10 mM NAC

1.46 + 0.02a

OxLDL + LPS

1.25 + 0.06b

LPS

1.22 + 0.1 1b

1 mM NAC + OxLDL + LPS

1.30 + 0.15b

5 mM NAC + OxLDL + LPS

1.24 + 0.05b

10 mM NAC + OxLDL + LPS

1.25 + 0.05b

20 mM NAC + OxLDL + LPS

0.29 + 0.14c

At the end of the experiments shown in Figure 3-10, macrophages were washed
with PBS and cellular DNA content was determined by the DPA assay as
described in Materials and Methods. Cell numbers were calculated from 532 nm
absorbance using a standard curve generated from varying numbers of cells.
Values are means + S.D. for triplicate samples. The means with different letter
superscripts indicate significantly different (p<0.05, one way ANOVA). The data
are representative of three separate experiments.
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Figure 3-11. Effect of NAC pre-treatment on the inhibition caused by 13-HPODE in LPS stimulated RAW264.7
macrophages. RAW264.7 macrophages were pre-incubated with indicated concentration of NAC for 8 hours before
treatment with 40 pM 13-HPODE and 100 ng/ml LPS. Data points represent means + S.D. of triplicate samples for a
single experiment. Treatment with LPS (##) is significantly different from that pre-treated with NAC (#). Treatments with
LPS and 13-HPODE (**) are significantly different from that pre-treated with NAC (*) (Student’s / test). These results are
representative of three separate experiments.
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TABLE 3-4

CELL DENSITY AFTER TREATMENT WITH NAC AND 13-HPODE
Treatment

106cells/well
(DPA DNA Assay)

Control

1.97 + 0.20a

10 mM NAC

1.81 + 0 .1 1 3

LPS

1.55 + 0.04b

HPODE + LPS

1 .3 5 + 0.13b

0.1 mM NAC + HPODE + LPS

1 . 4 6 + 0.14b

0.5 mM NAC + HPODE + LPS

1.46 + 0.18b

1.0 mM NAC + HPODE + LPS

1.53 + 0.12b

5.0 mM NAC + HPODE + LPS

1 .5 2 + 0.02b

10 mM NAC + HPODE + LPS

1 . 3 3 + 0.03b

20 mM NAC + HPODE + LPS

1.18 + 0.03°

At the end of the experiments shown in Figure 3-11, macrophages were washed
with PBS and cellular DNA content was determined by the DPA assay. Cell
numbers were calculated from 532 nm absorbance using a standard curve
generated from varying numbers of cells. Values are means + S.D. for triplicate
samples. The means with different letter superscripts indicate significantly
different (p<0.05, one way ANOVA). The data are representative of three
separate experiments.
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caused by 13-HPODE. The effects of NAC were concentration dependent. NAC
became effective at a concentration of 1.0 mM. Cell viability was maintained
above 95%. Cell numbers were not increased by NAC as assessed by DPA
DNA assay (Table 3-4). NAC, however, showed cytotoxicity when the
concentration reached 20.0 mM. NAC alone, however, did not induce NO
production in unstimulated macrophages. These data suggest that the inhibition
caused by 13-HPODE was attenuated by pre-treatment with NAC.

Part IV - The Regulation of Inducible Nitric Oxide Svnthase Gene Expression in
RAW264.7 Macrophages

OxLDL Decreases iNOS Protein Induced bv LPS in RAW264.7 Macrophages
To determine whether oxLDL decreases cellular iNOS levels, iNOS
protein was analyzed by Western blotting. After treatment of LPS stimulated
RAW264.7 macrophages with oxLDL, AcLDL, or LDL for 24 hours, NO
production by macrophages was determined in the medium (see Figure 3-5) and
cellular proteins were extracted. Figure 3-12 shows Western blotting of iNOS
protein in LPS stimulated RAW264.7 macrophages treated with oxLDL, AcLDL,
or LDL. A 130 kDa band identical to the iNOS protein standard (shown in Figure
3-13) was observed in LPS stimulated macrophages but not in unstimulated
macrophages. OxLDL significantly decreased iNOS protein levels induced by
LPS in RAW264.7 macrophages, whereas AcLDL and LDL only minimally
decreased iNOS protein levels. These results are consistent with the results
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Figure 3-12. Western blot of iNOS from LPS stimulated RAW264.7
macrophages treated with oxLDL. RAW264.7 macrophages were incubated with
100 ng/ml LPS and oxLDL dialysate, 50 pg/ml oxLDL, AcLDL or LDL for 24
hours. Cellular proteins were extracted and analyzed. Top panel shows the
photograph of the iNOS protein. Arrow indicates the approximate molecular
mass of 130 KDa from the standards run in parallel. The bottom panel is the
densitometry of iNOS. A representative of Western blot from three separate
experiments is shown.
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shown in Figure 3-5, which suggest that the decreased NO production caused by
oxLDL is due to the decreased iNOS protein levels.

13-HPODE Decreases iNOS Protein Induced bv LPS in RAW264.7
Macrophages
To determine whether 13-HPODE, and lysoPC have similar effects of
oxLDL in decreasing cellular iNOS protein levels, iNOS protein was analyzed by
Western blotting after treatment of LPS stimulated RAW264.7 macrophages with
13-HPODE or lysoPC for 24 hours. As shown in Figure 3-13, increasing
concentrations of 13-HPODE progressively decreased iNOS protein levels in
stimulated macrophages. LysoPC, at a concentration of 50 pM, had no
significant effect on iNOS protein levels compared to 13-HPODE (Figure 3-14).
Neither 13-HPODE nor lysoPC induced iNOS protein expression in unstimulated
RAW264.7 macrophages (data not shown).

OxLDL Decreases iNOS mRNA Induced by LPS in RAW264.7 Macrophages
To determine whether the decreased iNOS protein caused by oxLDL is
due to the decreased iNOS mRNA, Northern blots were performed on RNA
extracted from RAW264.7 macrophages stimulated with LPS for 6 hours in the
absence or presence of oxLDL. As shown in Figure 3-15, LPS induced iNOS
mRNA transcription whereas iNOS mRNA was undetectable in unstimulated
macrophages. OxLDL significantly decreased iNOS mRNA induced by LPS,
without altering GAPDH mRNA levels in RAW264.7 macrophages.
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Figure 3-13. Western blot of iNOS from LPS stimulated RAW264.7
macrophages treated with 13-HPODE. RAW264.7 macrophages were
incubated with 100 ng/ml LPS alone or plus 0, 5, 10, 20 or 35 pM 13-HPODE for
24 hours. Cellular proteins were extracted analyzed. Top panel shows the
photograph of the iNOS protein. Arrow indicates the approximate molecular
mass of 130 KDa from the standards run in parallel and the iNOS protein
standard is also shown on the right. The bottom panel is the densitometry of
iNOS. A representative of Western blot from four separate experiments is
shown.
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Figure 3-14. Western blot of iNOS from LPS stimulated RAW264.7
macrophages treated with 13-HPODE or lysoPC. RAW264.7 macrophages
were incubated with 100 ng/ml LPS alone or plus 10, 20 pM 13-HPODE or 50
pM lysoPC for 24 hours. Cellular proteins were extracted and analyzed. Top
panel shows the photograph of iNOS. Arrow indicates the approximate
molecular mass of 130 KDa from the standards run in parallel. The bottom panel
is the densitometry of iNOS. A representative of Western blot from four separate
experiments is shown.
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Figure 3-15. Northern blot of iNOS mRNA from LPS stimulated RAW264.7
macrophages treated with oxLDL. RAW264.7 macrophages were stimulated
with 100 ng/ml LPS in the absence or presence of 50 (ig/ml oxLDL for 6 hours.
Total mRNA was isolated and analyzed. Top panel shows the autoradiograph of
mRNA for iNOS and GAPDH, respectively. The bottom panel is the
densitometry of mRNA. A representative of Northern blot from three separate
experiments is shown.
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Activation of NF- k B Induced bv LPS in RAW264.7 Macrophages
To determine whether the induction of iNOS mRNA, and iNOS protein
was accompanied by the activation of NF-k B in macrophages, EMSA was
performed on nuclear proteins extracted from LPS stimulated RAW264.7
macrophages. Figure 3-16 shows the time course of NF-k B activation induced
by LPS. Nuclear extracts from unstimulated RAW264.7 macrophages showed
basal levels of NF-kB activity. The components of NF-k B complex were
identified by supershift assay using Rel antibodies against p50 (anti-p50) and
p65 (anti-p65) NF-k B subunits. As shown in Figure 3-17, the band labeled as
p50/p65 was shifted toward the origin by both anti-p50 and anti-p65 and
therefore being identified as the p50/p65 heterodimer, whereas the band labeled
as p50/p50 was shifted by anti-p50 but not anti-p65 and therefore being
identified as the p50/p50 homodimer. The bottom band being shifted by neither
anti-p50 nor anti-p65 was considered to be non-specific DNA binding. The top
band appeared in mixture with anti-Rel antibodies and considered supershift
band. Results shown in Figure 3-16 indicate that LPS markedly induced p65/p50
DNA binding activity which appeared after 30 minutes and reached a maximum
activation at 45 minutes. The activation of NF-k B lasted for at least 2 hours.

Effects of Oxidized Low Density Lipoprotein on the Activation of NF- k B in
RAW264.7 Macrophages
To determine whether oxLDL influences the activation of NF-k B in

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

69

m

Time (min)

o

CO

to
rf

CD

CNJ

p65/p50
p50/p50

w
^ 3

p50/p65
p50/p50

(/>
c

a>

Q

Figure 3-16. Activation of NF-k B induced by LPS in RAW264.7 Macrophages.
Macrophages were stimulated with 100 ng/ml LPS for varying legths of time.
The nuclear proteins were extrated and analyzed by the EMSA. Top panel
shows the NF-k B DNA binding activity. Arrows at the p50/p50 and p50/p65
indicate NF-k B homodimer and heterodimer proteins, respectively. The bottom
panel is the densitometry of the NF-k B bands. These results are representative
of two experiments.
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Figure 3-17. Supershift assay for identifying NF-k B proteins. Antibodies specific
to NF-k B p50 or p65 was added to the binding reaction mixture before the
precedures of EMSA. Arrows at the p50/p50 and p50/p65 indicate NF- k B
homodimer and heterodimer proteins. Respectively. These results are
representative of two experiments.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

71
RAW264.7 macrophages, nuclear proteins were extracted from macrophages
after co-incubation with LPS and oxLDL for 45 minutes. Figure 3-18 shows that
oxLDL alone did not induce p50/p65 NF-k B DNA binding activity in unstimulated
RAW264.7 macrophages. In contrast, the basal levels of p50/p65 activity were
suppressed by oxLDL. The activation of p50/p65 NF-k B DNA binding activity
induced by LPS was slightly suppressed by oxLDL in RAW264.7 macrophages.
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Figure 3-18. The influence of OxLDL on the activation of NF-k B induced by LPS
in RAW264.7 Macrophages. Macrophages were incubated with 100 ng/ml LPS
and 100 pg/ml oxLDL for 45 minutes. The nuclear proteins were extrated and
analyzed by the EMSA. The top panel shows NF-k B DNA binding activity.
Arrows at the p50/p50 and p50/p65 indicate NF-k B homodimer and heterodimer
proteins, respectively. The bottom panel is the densitometry of NF-k B bands.
These results are representative of three experiments.
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CHAPTER 4
DISCUSSION

Atherosclerosis appears to be a chronic inflammation of the vasculature
as indicated by the presence of macrophages, lymphocytes, immunoglubulins,
adhesion molecules, cytokines, colony stimulating factors as well as
inflammatory mediators such as NO and prostacyclin (PGI2) in atherosclerotic
lesions (Ross 1993). The activation of NF-k B (Brand and others 1996) and the
expression of iNOS in atherosclerotic plaques (Buttery and others 1996) further
confirm the presence of an active inflammatory process. Macrophages may
produce NO by iNOS in atherosclerotic lesions (Buttery and others 1996;
Leeuwenburgh and others 1997). Alterations in NO production by macrophages
may modulate atherogenesis (Lloyd-Jones and Bloch 1996).

The Inhibition Potential of Oxidized Low Density Lipoprotein
on NO Production
RAW264.7 macrophages produced large amounts of NO upon stimulation
with LPS (see Figure 3-1). The production of NO depended on the
concentrations of LPS, induction time and L-arginine supply. Under our
experimental conditions, RAW264.7 macrophages produced NO in a nearly
linear fashion. NO produced by cultured macrophages reacts with oxygen to
form unstable intermediates which decompose to N 0 2' and nitrate (N 0 3 ) (see
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reaction 3-1) (Marietta and others 1988). N 0 2' and N 0 3' have been shown to be
at a constant ratio of 2:3 in the medium of culture macrophages (Marietta and
others 1988). The iNOS gene from RAW264.7 macrophages has been cloned
and well characterized by Xie and others (1992). Goldring and others (1995)
also observed the activation of NF-k B in RAW264.7 macrophages after
stimulation with LPS. Furthermore, RAW264.7 cells had macrophage
characteristics in phagocytosis of latex beads and accumulation of oxLDL lipids
intracellularly as determined by O-red oil staining (data not shown). Via and
others (1985) also showed that RAW264.7 macrophages have AcLDL scavenger
receptors which take up AcLDL with the accumulation of cellular lipids. These
information suggest that RAW264.7 macrophages provide a useful model for
studying the effects of oxLDL on iNOS gene expression.

NO + 0 2 ------------ > N 0 2- + N 0 3-

(3-1)

We have previously studied the oxidation kinetics of human LDL (Ma and
others 1994). In the presence of tocopherols, the accumulation of LOOH in
oxLDL is very slow until all tocopherols were consumed. LOOH then
accumulates very rapidly in the absence of tocopherols. In the present study,
LDL was oxidized to the extent that all tocopherols were completely consumed
(see Figure 3-2). Jessep and others (1990) demonstrated that LDL is not
converted to a form that were recognized by scavenger receptors until all
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endogenous tocopherols are completely oxidized. LOOH accumulated in oxLDL
to increasing levels as a function of time (see Figure 3-2). The oxLDL used in
experiments described here would be taken up by macrophage scavenger
receptors. LDL contains 2332 nmol PUFA/mg protein with an octadecadienoic
acid content of about 2000 nmol/mg protein (for a review see Esterbauer and
others 1992). Most investigators determine the extent of LDL oxidation by
measuring MDA as a LOOH degradation product (Haberland and others 1982).
In most cases, it is not clear whether MDA is free or bound to oxLDL. We,
however, measured LDL associated LOOH directly used a colorimetric method
(Ma and others 1994; Tateishi and others 1987). We found that PUFAs are
almost completely oxidized to form a maximum of about 2300 nmol LOOH/mg
protein (see Figure 3-2). LOOH is the most abundant primary lipid peroxidation
product in LDL oxidized in vitro and probably in atherosclerotic lesions (Folcik
and Cathcart 1994, Folcik, 1995 #115; Noguchi and others 1993; Steinbrecher
and Pritchard 1989). LOOH exists as cholesterol hydroperoxides, phospholipid
hydroperoxides and free LOOH in oxLDL. The native LDL used in our
experiments contained very low concentrations of LOOH and had tocopherol
(mainly a-tocopherol) levels of about 21.4 nmol/mg protein. This LDL would be
taken up by the LDL receptor but not the scavenger receptors.
In agreement with Yang and others (1994), our data show that oxLDL was
a more effective inhibitor of NO production in LPS stimulated macrophages than
AcLDL or LDL (see Figure 3-5). Nonetheless, macrophages take up both AcLDL
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and oxLDL with an almost equal accumulation of intracellular lipids (Yang and
others 1994). Furthermore, the effects of AcLDL and LDL on NO production are
very similar, even though AcLDL is taken up by AcLDL scavenger receptors
whereas LDL is taken up by the LDL receptor. Therefore, neither the binding of
modified LDL to AcLDL scavenger receptors nor lipid loading are likely to
account for the observed inhibition of NO production. These results further
support the notion that the inhibition potential of oxLDL may be determined by
LOOH levels in oxLDL.
The slight inhibitory effect of AcLDL and LDL may be due to several
factors. Both AcLDL and LDL contained trace amounts of LOOH that would also
increase slightly during the 24 hours of incubation with macrophages (Aviram
and Rosenblat 1994). The LOOH in AcLDL and LDL, even as low as 30-50
nmol/mg protein may cause inhibition. Suzuki and others (1997b) suggested in a
recent review that the ligand-receptor coupling such as TNF-a receptor binding
would produce reactive oxygen species. We cannot exclude the possibility that
ligation of AcLDL with AcLDL scavenger receptors or LDL with the LDL receptor
would also produce reactive oxygen species, which give rise to a slight inhibition.
Furthermore, whether class B scavenger receptors that only recognize oxLDL
but not AcLDL (Sparrow and others 1989) are involved in the strong inhibitory
effect of oxLDL has not been explored.
OxLDL at the concentrations used in this study did not decrease cell
viability or mitochondrial dehydrogenase activity as determined by the MTT
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assay. Furthermore, oxLDL prepared by our method is free of Fe** and Cu~
ions, and may have lower cytotoxicity compared to oxLDL prepared with these
transition metal ions. Coffey and others (1995) suggest that Fe** increases
oxLDL cytotoxicity by causing the breakdown of LOOH to toxic LO’ and 'OH
radicals and aldehydes.

13-HPODE and LvsoPC on NO Production in LPS Stimulated Macrophages
13-HPODE and lysoPC have been shown by other investigators to be the
major products formed during LDL oxidation (Folcik and others 1995; Noguchi
and others 1993; Steinbrecher and others 1990). We are the first to find that 13HPODE was markedly more effective than lysoPC for inhibiting NO production by
stimulated RAW264.7 macrophages (see Figure 3-6). 13-HPODE is a product
formed when octadecadienoic acid at 2-position of phosphatidylcholine (PC) is
oxidized and hydrolyzed by the PLA2 activity of oxLDL (see reaction 1-1).
Compared to 13-HPODE, LOOH in oxLDL was found to be less effective as an
inhibitor of NO production (see Figure 3-4 and 3-7), which suggests that
unesterified LOOH may be a better inhibitor than esterified LOOH.
As shown in Figure 3-6, lysoPC at 50 |iM had no significant effect on NO
production (see Figure 3-6). LysoPC is the second major product formed during
LDL oxidation. LDL contains about 1500 nmol phospholipids/mg protein with PC
at a level of 818 nmol/mg protein (Esterbauer and others 1992).

LysoPC

reaches 400-600 nmol/mg protein in extensively oxidized LDL (Steinbrecher and
others 1990). Extensively oxidized LDL at a concentration of 100 jj.g protein/ml
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has lysoPC about 40-60 pM, which is the concentration we used in our study.
Therefore, lysoPC is unlikely to be a major contributor for the inhibitory effect of
oxLDL on NO production.
The data in Figure 3-6 also show that the inhibitory effects of 13-HPODE
and lysoPC on NO production were very similar in AcLDL carrier or BSA carrier.
In the concentration dependent experiments shown in Figure 3-7 and 3-8, both
13-HPODE and lysoPC in BSA carrier showed inhibition of NO production, with
13-HPODE being more potent than lysoPC. These results suggest that the
effects of 13-HPODE and lysoPC did not require an AcLDL carrier. In the
present study, we have not determine the mechanisms for the uptake of 13HPODE by macrophages. However, we found that 13-HPODE levels decreased
when 13-HPODE was incubated with macrophages and were undetectable after
24 hours (data not shown). In the Fe~ free RPMI medium, 13-HPODE is
unlikely to decompose to LO\ and 'OH radicals, and aldehydes. Cellular GSH
peroxidases would be expected to reduce 13-HPODE to 13-HODE with a
transient consumption of intracellular GSH (see reaction 1-3) (Coffey and others
1995; Schmitt and others 1995).

Antioxidants on Nitric Oxide Production
In the experiment shown in Figure 3-5, AcLDL and LDL only slightly
inhibited NO production in macrophages compared to oxLDL. AcLDL and LDL
contained not only low levels of LOOH but also high levels of a-tocopherol.
Macrophages take up AcLDL with the accumulation of lipids as well as
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intracellular a-tocopherol. Whether the high in intracellular a-tocopherol also
contributes to modulating NO production has not been previously investigated.
We loaded macrophages with a-tocopherol by pre-incubation with a-tocopherol
containing liposomes. Macrophages took up liposomes by phagocytosis and the
cellular a-tocopherol in macrophages increased dramatically compared to
macrophages loaded with control liposomes containing no tocopherol. As shown
in Figure 3-9, increased cellular a-tocopherol attenuated the inhibition due to
oxLDL by about 35% compared to cells treated with control liposomes, aTocopherol has been shown by Schmitt and others (1995) to inhibit the GSH and
ATP depletion caused by oxLDL in cultured endothelial cells. Kuzuya and others
(1991) also observed that loading of endothelial cells and macrophages with atocopherol or probucol reduced oxidative injury due to oxLDL. The intracellular
content of a-tocopherol may, therefore, be important for reducing cellular
oxidative stress. Recently, increased evidence also shows that intracellular atocopherol prevents the impairment of EDRF mediated relaxation due to oxLDL
as well as inhibits SMC proliferation and monocyte adhesion on endothelium
(Devaraj and others 1996; Keaney and others 1996; Ozer and others 1993).
The inhibition on cellular PKC activity has been suggested to contribute, in part,
to the cellular effects of a-tocopherol (Devaraj and others 1996; Keaney and
others 1996; Ozer and others 1993). These results suggest that a-tocopherol
containing liposomes provide an effective way to increase tissue tocopherol
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levels and would therefore provide a unique approach for pharmacological
intervention.
The data in figure 3-10 and 3-11 show that pre-treatment of macrophages
with NAC also attenuated the inhibitory effects of oxLDL and 13-HPODE on NO
production. NAC serves as an antioxidant by scavenging radicals and by
increasing intracellular GSH levels (Moldeus and Cotgreave 1994; van 1995).
Both oxLDL and LOOH has been shown to deplete intracellular GSH levels
(Hennig and others 1996; Schmitt and others 1995; Thomas and others 1993).
Phospholipid hydroperoxide glutathione peroxidase (PHGPX) is a 18kDa
selenoprotein expressed in cells (Maiorino and others 1991). PHGPX reduces
LOOH in oxLDL to LOH and 13-HPODE to 13-HODE using GSH as a substrate.
OxLDL and 13-HPODE, therefore causing the consumption of intracellular GSH.
Treatment of macrophages with NAC reversed the inhibition of NO production
due to oxLDL and 13-HPODE. These results further suggest that the inhibition of
oxLDL and 13-HPODE on NO production may be mediated by redox sensitive
mechanisms. Increased intracellular a-tocopherol or NAC may preserve NO
production in macrophages. The present study also suggest a possible
pharmacological strategy for intervention in atherosclerotic process.

Regulation of iNOS Gene
The data in Figure 3-12 and 3-15 show that LPS induced the expression
of iNOS in RAW264.7 macrophages, whereas oxLDL significantly decreased
iNOS expression by decreasing iNOS protein and iNOS mRNA. Yang and
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others (1994) found that oxLDL inhibits isolated cytosolic iNOS activity.
Nevertheless, our study indicates that a decreased expression of iNOS caused
by oxLDL may be the major contributor for the decreased NO production.
OxLDL decreased iNOS mRNA levels, presumably by inhibit ng the transcription
of iNOS gene in macrophages as found in endothelial cells by Liao and others
(1995).
The induction of mouse iNOS gene is regulated by N F- k B, AP-1 and other
transcription factors (Xie and others 1994; Xie 1997). As shown in Figure 3-16,
LPS was found to activate N F- k B in RAW264.7 macrophages. These results
confirm that the activation of N F- k B is important for the expression of iNOS as
suggested by others (Goldring and others 1995; Xie and others 1994). W e also
showed that oxLDL slightly suppressed the activation of N F - k B 45 minutes after
incubation (see Figure 3-18). The suppression of N F- k B activation was in
agreement with the decreased iNOS mRNA and iNOS protein shown in Figure 313 and 3-15, respectively. The slight suppression of N F- k B, however, is not
sufficient enough to explain the dramatic decrease of iNOS mRNA levels in this
experiment. An increased post-transcriptional degradation of iNOS mRNA can
not be excluded. Others investigators (Ohlsson and others 1996; Schackelford
and others 1995) have found that oxLDL almost completely suppresses N F - k B
activation in mouse peritoneal macrophages. Furthermore, several studies
(Hamilton and others 1995; Ohlsson and others 1996; Schackelford and others
1995) also show that oxLDL inhibits the expression of other N F- k B regulated
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genes such as TNF-a, IL-1a and IL-1 p. These further support the notion that
oxLDL inhibits iNOS expression at least in part at the transcriptional level.
If the suppression of iNOS gene expression was due to the suppression of
N F - k B then we would expect to see a marked suppression of N F- k B with oxLDL,

but this was not observed as shown in Figure 1-18. Compared to study of
Ohlsson and others (1996) who treated macrophages with oxLDL for 24 hours
before stimulation with LPS, we only treated cells with oxLDL plus LPS for 45
minutes. It might be possible that macrophages were not exposure to oxLDL
sufficient long to elicit a strong inhibition in our experiments. It is also possible
that the activation of N F- k B is required but not sufficient for the expression of
iNOS, as suggested by others (Flodstrom and others 1996; Kuo and others
1997). Additional transcription factors such as AP-1 may also regulate iNOS
transcription (Flodstrom and others 1996; Kuo and others 1997; Xie and others
1994). N F - k B probably acts in concert with adjacent cis-elements that are
activated by extracellular signals to form an effective initiation transcription
complex (Collins 1993). In other words, the suppression of AP-1 or other
transcription factors could also inhibit iNOS gene expression. Interestingly, AP-1
is also a redox sensitive transcription factor (Flohe and others 1997). Unlikely
N F - k B, AP-1 is inhibited by oxidants (Flohe and others 1997). Therefore, oxLDL

may suppress AP-1 activation thereby inhibiting iNOS expression. At the present
time, only very limited information is available on the role of AP-1 on the
regulation of the iNOS gene in macrophages.
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The results shown in Figure 3-12, 3-15 and 3-18 clearly show that oxLDL
neither induced iNOS nor activated NF-k B in macrophages. Our results, along
with that of others (Hamilton and others 1995; Ohlsson and others 1996;
Schackelford and others 1995; Thai and others 1995) do not fit the simple model
shown in Figure 1-3 in which oxidants activate NF- k B and antioxidants block this
effect. Regulation of gene expression by NF-k B is complex, the activation of
p50/p65 activates gene expression, whereas the activation of p50/p50 may be
inhibitory thereby suppressing gene expression (Franzoso and others 1992;
Plaksin and others 1993). Schackelford and others (1995) have discussed the
possibility that oxLDL induces an unidentified complex that competes with
p50/p65 binding to the NF-k B DNA sequence thereby inhibits TNF-a expression.
However, results from the present study did not show a dramatic activation of
p50/p50 dimer that could inhibit p50/p65 binding.
Recent evidence suggests that the induction of N F - k B by oxidative stress
may be cell type specific (Brennan and O'Neill 1995; Grigoriadis and others
1996; Hecker and others 1996). In endothelial cells, oxLDL indeed induces NFkB

as well as NF- k B regulated genes such as adhesion molecules (i.e., VCAM-1,

ELAM-1, ICAM-1), colony stimulating factors (i.e., GM-CSF, M-CSF),
chemoattratant (i.e., MCP-1), and cytokines (i.e., IL-6, IL-8, IFN-p) (fora review
see Collins 1993; Collins and others 1995). This is a typical example of the
model shown in Figure 1-4.

However, macrophages behave differently

compared to endothelial cells in that intracellular GSH depletion due to oxLDL
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continues in endothelial cells but rebounds, and then exceeds the resting GSH
levels in macrophages by increasing GSH biosynthesis (Darley-Usmar and
others 1991; Faruqi and others 1997). Furthermore, NF-k B has been suggested
to have dual effects on macrophages (Sato and others 1995). Macrophages
may have superior abilities to deal with oxidative stress because they can
generate oxidative bursts upon stimulation by pathogens. Endothelial cells may
be more susceptible to oxidative stress than macrophages.
Oxidative stress also induces heat shock proteins (HSP) that protect
against environmental stress. HSP70, for instance, was induced in cultured
human endothelial, and SMC by treatment with oxLDL (Pirillo and others 1997;
Zhu and others 1994; Zhu and others 1995). Significantly, several studies
(Berberian and others 1990; Johnson and others 1993) have found an increased
expression of HSP70 in human, and rabbit atherosclerotic arteries. Furthermore,
HSP70 has been shown to inhibit the activation of NF-k B, and the expression of
iNOS in arterial SMC, and astroglial cells (Feinstein and others 1996; Wong and
others 1995). Suppression of NF-k B caused by oxLDL may be a secondary
response of HSP induction. This may explain the slight inhibition of NF- k B
caused by oxLDL as shown in Figure 3-18, because the secondary suppression
of NF-k B due to the induction of HSP70 may not be obvious as early as 45
minutes. HSP70 is, therefore, a possible link between oxLDL and decreased
iNOS mRNA levels in macrophages.
We are the first to find that 13-HPODE mimicked the effect of oxLDL on
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decreasing iNOS protein in LPS stimulated macrophages (see Figure 3-13).
LysoPC, however, at almost twice of the concentration for 13-HPODE, had no
significant effect (see Figure 3-14). These results further suggest the
involvement of oxidative stress in iNOS gene expression because both 13HPODE and oxLDL would induce intracellular oxidative stress by the
consumption of GSH but lysoPC would not have this effect (Darley-Usmar and
others 1991; Faruqi and others 1997; Hennig and others 1996). Furthermore,
intracellular a-tocopherol or pre-treatment with NAC attenuated the inhibition on
NO production caused by oxLDL or 13-HPODE (see Figure 3-9, 3-10 and 3-11).
Oxidative stress, therefore, is a plausible mechanism for inhibiting NO production
in stimulated macrophages.

Physiological Significance

Inducible Nitric Oxide Production and Atherosclerosis
Inducible NO production from macrophages may be important for
modulating in vivo LDL oxidation (Leeuwenburgh and others 1997; Rubbo and
others 1994). Macrophages produce NO by iNOS using L-arginine and 0 2 as
substrates and NADPH as a co-factor. 0*2' is thought to be produced by NADPH
oxidase. The potential physiological significance of diminished NO production by
macrophages in the arterial intima due to oxLDL may be partly dependent upon
the localized 0*2‘ production (Rubbo and others 1994). NO may act as an
antioxidant under conditions where local production of 0 '2' is low (Jessup and
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Dean 1993; Rubbo and others 1994). In this case, the diminished production of
NO by oxLDL could promote atherosclerosis. In contrast, if the localized 0"2'
level is high, then a diminished production of NO would decrease ONOO'' levels
and prevent the pro-atherogenic effects caused by this oxidant (Hogg and others
1993). A recent study indicates that in L-arginine depleted macrophages, iNOS
produces both NO and 0 ’2' (Xia and Zweier 1997). Significantly, low L-arginine
levels are associated with increased atherogenesis (Naruse and others 1994).
The co-production of NO and 0 ‘2' by iNOS leads to the production of ONOO*'
which may be important in atherosclerosis (Leeuwenburgh and others 1997;
Rubbo and others 1994). The induction of iNOS in macrophages, therefore, may
play an important role in initiating or modulating the process of atherosclerosis.

Antioxidants and Nitric oxide Production
Antioxidants have been implicated in decreasing the incidence of
cardiovascular disease. Antioxidants, specially a-tocopherol, protects LDL
against lipid peroxidation. The present study provides evidence that extocopherol preserved NO production in macrophages treated with oxLDL. Our
results support the hypothesis of Diaz (Diaz and others 1997) that a-tocopherol
has direct effects on tissues in preventing atherosclerosis. We also found that
NAC reversed the inhibition of NO production caused by oxLDL or 13-HPODE.
Therefore, a-tocopherol and NAC may modulate the process of atherosclerosis
by preserving NO production that otherwise would be impaired by oxLDL.
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Atherosclerosis and Infection
Accumulating evidence suggests that infectious microorganisms may play
a role in atherosclerosis. The most prevalent pathogen related to atherosclerosis
is chlamydia (Mlot 1996). Chlamydia was consistently found with high incidence
in human atherosclerotic plaques using in PCR techniques (Jackson and others
1997; Kuo and others 1993). Chlamydia is a special type of bacteria that lives as
a parasite in macrophages, and contains LPS (Toman and others 1997).
Although we do not understand how chlamydia is related to atherosclerosis,
chlamydia is unlikely to be an accidental deposit in pre-existing atherosclerotic
lesions (Mlot 1996). Chlamydia infection could produce signals that modulate
macrophage functions such as the induction of iNOS.
Similarly, infectious viruses such as cytomegalovirus (CMV) and herpes
simplex virus (HSV) have been linked to atherosclerosis (for a review see Hajjar
and Nicholson 1997). CMV and HSV have also been found in human
atherosclerotic lesions and transplanted hearts. Infection of cultured endothelial
cells, or animal models with HSV produces alterations similar to those observed
in chronic atherosclerotic lesions (Jacob and others 1992). HSV infected
macrophages have been shown to adhere to endothelium via scavenger
receptor class B (Suzuki and others 1997a). Furthermore, both CMV and HSV
are able to activate NF-kB, and may initiate an atherosclerotic-like process (Speir
and others 1996).
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CONCLUSIONS
Our study indicates that the levels of LOOH in oxLDL determine the
inhibition potential of oxLDL on NO production in LPS stimulated RAW264.7
macrophages. This inhibition is not due to oxLDL cytotoxicity. 13-HPODE
markedly inhibits NO production compared to lysoPC. These data suggest that
LOOH in oxLDL may be more important than lysoPC for inhibiting NO
production. Both a-tocopherol and NAC attenuate the inhibitory effects of oxLDL
and 13-HPODE. OxLDL also decreases iNOS protein and mRNA levels. OxLDL
suppresses the expression of iNOS gene, possibly at the transcriptional level.
The present study, therefore, suggests that the atherogenic properties of oxLDL
may, in part, be mediated by modulating NO production in macrophages.
Oxidative stress may be a possible mechanism for regulation of iNOS gene
expression by oxLDL. Preservation of NO production may contribute to the antiatherosclerotic effects of antioxidants. This study also suggests that the
regulation of NO production may be a target for future intervention studies of
atherosclerosis.
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